Skip to main content
Equibles
GKOS logo

GKOS · GLAUKOS Corp · Earnings Call Transcripts & Audio

Track GKOS — free

Use GKOS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GKOS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$164.19 +5.64 (+3.56%) At close · Sep 30
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$9.11B
Shares
58.98M
Volume · Sep 30 947.09K Avg daily vol (3M) 796.93K

GLAUKOS Corp Earnings Call Transcripts

Quarterly earnings calls for GLAUKOS Corp (GKOS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼4.6% $71.27M −$27.58M '22 Q3 22-11-02 ▼2.7% $71.23M −$31.46M '22 Q4 23-02-22 ▲9.2% $73.90M −$34.63M '23 Q1 23-05-03 ▲10.6% $80.40M −$32.81M '23 Q2 23-08-02 ▲9.5% $78.05M −$30.44M '23 Q3 23-11-01 ▲15.6% $82.36M −$36.78M '23 Q4 24-02-21 ▲15.9% $85.62M −$40.84M '24 Q1 24-05-01 ▲19% $95.69M −$50.55M '24 Q2 24-07-31 ▲23.9% $96.67M −$21.41M '24 Q3 24-11-04 ▲28.1% $105.50M −$33.58M '24 Q4 25-02-20 ▲24.6% $106.66M −$18.15M '25 Q1 25-05-27 ▲29.7% $124.12M −$19.66M '25 Q2 25-07-30 ▲38.1% $133.54M −$16.23M '25 Q3 25-10-29 ▲35.7% $143.12M −$133.66M '25 Q4 26-02-17 ▲41.2% $150.57M −$19.78M '26 Q1 26-04-29 LATEST ▲49.5% $185.61M −$18.38M '26 Q2 26-07-29
Conference
Investor event
2026-09-09
GLAUKOS Corp (GKOS) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-29
GLAUKOS Corp (GKOS) Q2 2026 Earnings Call Transcript
Confident tone Epioxa (corneal cross-linking) launch iDose TR (U.S. Glaucoma) growth iDose re-administration and cannibalization
Revenue
$185.61M
▲ 49.5% YoY
Diluted EPS
$-0.31
Gross margin
81.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-16
GLAUKOS Corp (GKOS) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
GLAUKOS Corp (GKOS) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-02
GLAUKOS Corp (GKOS) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-29
GLAUKOS Corp (GKOS) Q1 2026 Earnings Call Transcript
Confident tone Epioxa launch and corneal cross-linking Reimbursement, access, and payer dynamics iDose TR commercial momentum
Revenue
$150.57M
▲ 41.2% YoY
Diluted EPS
$-0.34
Gross margin
77.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
GLAUKOS Corp (GKOS) Q4 2025 Earnings Call Transcript
Confident tone Photrexa transition to Epioxa Pipeline and R&D investment Epioxa launch and keratoconus market development
Revenue
$143.12M*
▲ 35.7% YoY
Gross margin
-1.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
GLAUKOS Corp (GKOS) Q3 2025 Earnings Call Transcript
Confident tone Epioxa FDA approval and launch Corneal Health / Photrexa Medicaid rebate impact iDose TR launch momentum
Revenue
$133.54M
▲ 38.1% YoY
Diluted EPS
$-0.28
Gross margin
78.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
GLAUKOS Corp (GKOS) Q2 2025 Earnings Call Transcript
Confident tone International Growth & EU Approvals Capital Allocation / Cash Flow MIGS / Stent Market Headwinds (MAC LCDs)
Revenue
$124.12M
▲ 29.7% YoY
Diluted EPS
$-0.34
Gross margin
78.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-27
GLAUKOS Corp (GKOS) Q1 2025 Earnings Call Transcript
Confident tone iDose TR launch and adoption Interventional glaucoma (IG) category development Corneal health and Epioxa pipeline
Revenue
$106.66M
▲ 24.6% YoY
Diluted EPS
$-0.32
Gross margin
77.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
GLAUKOS Corp (GKOS) Q4 2024 Earnings Call Transcript
Confident tone 2025 Financial Guidance Reimbursement and Market Access iDose TR Commercial Launch
Revenue
$105.50M*
▲ 28.1% YoY
Gross margin
72.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
GLAUKOS Corp (GKOS) Q3 2024 Earnings Call Transcript
Confident tone Reimbursement and J-code Progress MIGS LCD Coverage and Medicare Advantage iDose TR Commercial Launch
Revenue
$96.67M
▲ 23.9% YoY
Diluted EPS
$-0.39
Gross margin
76.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
GLAUKOS Corp (GKOS) Q2 2024 Earnings Call Transcript
Positive tone iDose TR Launch Operating Expenses / Financial Outlook U.S. Interventional Glaucoma Franchise / iStent
Revenue
$95.69M
▲ 19% YoY
Diluted EPS
$-1.00
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
GLAUKOS Corp (GKOS) Q1 2024 Earnings Call Transcript
Confident tone U.S. glaucoma franchise growth iDose TR launch and commercial rollout iDose TR reimbursement and market access
Revenue
$85.62M
▲ 15.9% YoY
Diluted EPS
$-0.82
Gross margin
76.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
GLAUKOS Corp (GKOS) Q4 2023 Earnings Call Transcript
Confident tone U.S. Glaucoma Franchise / iStent infinite iDose TR Launch Pipeline / R&D
Revenue
$82.36M*
▲ 15.6% YoY
Gross margin
77.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
GLAUKOS Corp (GKOS) Q3 2023 Earnings Call Transcript
Revenue
$78.05M
▲ 9.5% YoY
Diluted EPS
$-0.63
Gross margin
76.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
GLAUKOS Corp (GKOS) Q2 2023 Earnings Call Transcript
Revenue
$80.40M
▲ 10.6% YoY
Diluted EPS
$-0.68
Gross margin
75.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
GLAUKOS Corp (GKOS) Q1 2023 Earnings Call Transcript
Revenue
$73.90M
▲ 9.2% YoY
Diluted EPS
$-0.72
▼ 754.5% YoY
Gross margin
75.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
GLAUKOS Corp (GKOS) Q4 2022 Earnings Call Transcript
Revenue
$71.23M
▼ 2.7% YoY
Diluted EPS
$-0.66
▼ 240.4% YoY
Gross margin
75.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
GLAUKOS Corp (GKOS) Q3 2022 Earnings Call Transcript
Revenue
$71.27M
▼ 4.6% YoY
Diluted EPS
$-0.58
▼ 546.2% YoY
Gross margin
76.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
GLAUKOS Corp (GKOS) Q2 2022 Earnings Call Transcript
Revenue
$72.69M
▼ 6.9% YoY
Diluted EPS
$-0.96
Gross margin
75.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-23
GLAUKOS Corp (GKOS) Q1 2022 Earnings Call Transcript
Revenue
$67.68M
▼ 0.4% YoY
Diluted EPS
$0.11
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
GLAUKOS Corp (GKOS) Q4 2021 Earnings Call Transcript
Revenue
$73.24M
▲ 0% YoY
Diluted EPS
$0.47
Gross margin
77.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
GLAUKOS Corp (GKOS) Q3 2021 Earnings Call Transcript
Revenue
$74.71M
▲ 15.2% YoY
Diluted EPS
$0.13
Gross margin
79.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
GLAUKOS Corp (GKOS) Q2 2021 Earnings Call Transcript
Revenue
$78.09M
▲ 147.5% YoY
Diluted EPS
$-0.38
Gross margin
77.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
GLAUKOS Corp (GKOS) Q1 2021 Earnings Call Transcript
Revenue
$67.97M
▲ 22.8% YoY
Diluted EPS
$-0.36
Gross margin
75.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
GLAUKOS Corp (GKOS) Q4 2020 Earnings Call Transcript
Revenue
$73.23M
▲ 11.2% YoY
Diluted EPS
$-0.24
▼ 128.6% YoY
Gross margin
73.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
GLAUKOS Corp (GKOS) Q3 2020 Earnings Call Transcript
Revenue
$64.83M
▲ 10.8% YoY
Diluted EPS
$-0.35
Gross margin
72.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
GLAUKOS Corp (GKOS) Q2 2020 Earnings Call Transcript
Revenue
$31.56M
▼ 46.1% YoY
Diluted EPS
$-0.90
Gross margin
31.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
GLAUKOS Corp (GKOS) Q1 2020 Earnings Call Transcript
Revenue
$55.34M
▲ 2.4% YoY
Diluted EPS
$-1.24
Gross margin
41.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-28
GLAUKOS Corp (GKOS) Q4 2019 Earnings Call
Revenue
$65.85M
▲ 21.8% YoY
Diluted EPS
$0.84
▲ 2000% YoY
Gross margin
75.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–31 of 31 earnings calls
Key facts CIK 1192448 CUSIP 377322102 13F (30d) 11 filings 10 filers Visit website Investor relations